BDX
$188.89 · +0.8% today · +4.8% 5d · +18.8% 3m · +31.9% 1y
Daily score31
Weekly score43
Long-term score89
Close
Scores (0–100)
Components — latest (2026-10-14)
Close
188.89
1D return
+0.8%
5D return
+4.8%
Rel volume
0.91
CMF 20
0.06
OBV slope 20
-0.31
Up-vol ratio 10
0.48
Short ratio
0.38
Short ratio Δ
−0.9%
Persistence 10
0.00
Inflow mean 5d
-0.08
Inflow mean 60d
0.46
Momentum 12-1
+29.9%
% of 52w high
+99.0%
vs 200d
+16.6%
Volatility 60d
+24.7%
Dollar vol 20d
$329.04M
Insider buys 90d
$0
Insider buyers 90d
0.00
Revenue growth
+5.4%
Fundamentals — Becton Dickinson · Health Care
as of 2026-10-22- P/E
- 32.5
- P/B
- 2.24
- ROE
- 6.9%
- Operating margin
- 11.8%
- Debt / equity
- 0.55
- FCF yield
- —
- Years profitable
- 5/5
- BM score
- 16
- Moat flag
- No
Insider trades (Form 4)
| Filed | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-09-29 | Feld Michael | EVP, Chief Revenue Officer | Sell | 76 | $183.70 | $14.0K |
| 2026-08-27 | Feld Michael | EVP, Chief Revenue Officer | Sell | 165 | $188.49 | $31.1K |
| 2026-08-14 | Polen Thomas E Jr | Chairman, CEO and President | Sell | 4.2K | $185.00 | $768.1K |
| 2026-08-12 | Goette Roland | EVP and President, EMEA | Sell | 2.4K | $180.84 | $440.9K |
| 2026-07-28 | Feld Michael | EVP, Chief Revenue Officer | Sell | 75 | $157.13 | $11.8K |
| 2026-06-26 | Feld Michael | EVP, Chief Revenue Officer | Sell | 75 | $152.80 | $11.5K |
| 2026-06-25 | Garrison Michael David | EVP & Pres Med.Essntl&BioPharm | Sell | 1.1K | $145.66 | $160.2K |
| 2026-06-11 | Garrison Michael David | EVP & Pres Med.Essntl&BioPharm | Sell | 1.1K | $151.48 | $166.6K |
| 2026-06-03 | Polen Thomas E Jr | Chairman, CEO and President | Sell | 2.8K | $146.35 | $404.5K |
| 2026-05-27 | Feld Michael | EVP, Chief Revenue Officer | Sell | 75 | $147.35 | $11.1K |
| 2026-04-28 | Feld Michael | EVP, Chief Revenue Officer | Sell | 74 | $151.94 | $11.2K |